Kainos Group plc Total Voting Rights (2813K)

TIDMKNOS

RNS Number : 2813K

Kainos Group plc

31 December 2020

31 December 2020

Kainos Group plc

("Kainos" or the "Company")

Total Voting Rights

Pursuant to DTR 5.6.1 the Company announces that as at 31 December 2020, the total number of ordinary shares in issue now stands at 122,640,887 each with voting rights. There are no shares held in treasury.

The above figure (122,640,887) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47

Classification : 2.5 - Total number of voting rights and capital

Ends

For further information, please contact:

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Investec Bank plc [phone]

Patrick Robb / Ben Griffiths

Canaccord Genuity [phone]

Simon Bridges/ Emma Gabriel

FTI Consulting LLP [phone]

Matt Dixon / Dwight Burden / Kwaku Aning

About Kainos

Kainos Group plc is a UK-headquartered provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

The Group's Digital Platforms comprise specialised digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for the digitisation of patient notes in the Acute sector of the NHS.

Kainos has over 1,700 people across 15 offices in Europe and North America.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRKFLBXBLLEFBV

(END) Dow Jones Newswires

December 31, 2020 05:00 ET (10:00 GMT)